Loading...

TYRA TYRA BIOSCIENCES INC Capital Structure Changes 8-K Filing

TYR

TYR

TYRA BIOSCIENCES INC

(TYRA)

2026 8-K

Financial Results

Board Appointment

Management Change

Financial Results Announced

Management Change

Financial Results Announcement

Clinical Study Update

Financial Results Report

Product Expansion

Financial Statements

Financial Results

Financial Results

Director Resignation

Equity Exchange

Financial Results Announcement

Annual Meeting and Liabilit...

Financial Results Announcement

Appointment of Directors

Earnings Reports

Private Placement

FDA Designation for TYRA-30...

Initiation of SURF201 Phase...

Earnings Reports

Amended and Restated Bylaws

Financial Results Announcement

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

Incentive Plan Adoption and...

External Links:

On March 4, 2026, Tyra Biosciences, Inc. agreed to sell 4 million shares of common stock to an investment firm for $31.50 each, expecting gross proceeds of $126 million.

AI Assistant

TYRA BIOSCIENCES INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.